$RXII $3.33
MVP big board pick by Bhuson.


Shares Outstanding: 16.10M
Float: 11.47M [/b]


10-Q 8/14/14

56% Buy


Press Releases

Wednesday, September 3, 2014
RXi Pharmaceuticals to Present at the Rodman & Renshaw 16th Annual Global Investment ConferencePR Newswire

Thursday, August 14, 2014
RXi Pharmaceuticals Reports Financial Results for the Second Quarter of 2014PR Newswire

Thursday, August 7, 2014
RXi Pharmaceutical Corporation (NASDAQ: RXII) to Ring The NASDAQ Stock Market Closing BellGlobeNewswire

Monday, August 4, 2014
RXi Pharmaceuticals to Ring the NASDAQ Stock Market Closing BellPR Newswire

Wednesday, July 30, 2014
RXi Pharmaceuticals Expands Clinical Program with Initiation of Third Phase 2a Study with RXI-109 for Treatment of Hypertrophic ScarsPR Newswire

Wednesday, July 9, 2014
What RXi Pharmaceuticals’ Move to the Russell Microcap Index MeansAccesswire

Monday, July 7, 2014
RXi Pharmaceuticals Appoints Peter Campochiaro M.D. to its Scientific Advisory BoardPR Newswire

Wednesday, July 2, 2014
RXi Pharmaceuticals Celebrates Expansion of its Operations in MassachusettsPR Newswire

Wednesday, June 25, 2014

RXi Pharmaceuticals Set to Join Russell Microcap IndexPR Newswire
Monday, June 9, 2014

RXi Pharma Advances sd-rxRNA Platform with Key PatentAccesswire
Tuesday, May 27, 2014

RXi Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare ConferencePR Newswire

Thursday, May 22, 2014
RXi Pharmaceuticals Granted US Notice of Allowance Covering Self-Delivering (sd-rxRNA) Technology PlatformPR Newswire

Wednesday, May 14, 2014
RXi Pharmaceuticals Reports Financial Results for the First Quarter of 2014PR Newswire